Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach

(1) Background: Prostate-specific membrane antigen (PSMA) has been extensively studied in the last decade. It became a promising biological target in the diagnosis and therapy of PSMA-expressing cancer diseases. Although there are several radiolabeled PSMA inhibitors available, the search for new co...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahnif, Hanane, Grus, Tilmann, Pektor, Stefanie, Greifenstein, Lukas, Schreckenberger, Mathias, Rösch, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588462/
https://www.ncbi.nlm.nih.gov/pubmed/34770742
http://dx.doi.org/10.3390/molecules26216332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588462/
https://www.ncbi.nlm.nih.gov/pubmed/34770742
http://dx.doi.org/10.3390/molecules26216332

Ejemplares similares